Australia markets close in 59 minutes

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3256+0.0150 (+4.83%)
At close: 03:58PM EST
0.3255 -0.00 (-0.03%)
After hours: 05:15PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
6,668
7,592
6,493
4,065
1,969
Selling general and administrative
3,161
2,945
2,634
2,444
2,355
Total operating expenses
9,828
10,537
9,127
6,509
4,324
Operating income or loss
-9,828
-10,537
-9,127
-6,509
-4,324
Total other income/expenses net
-
-
-
122.4
-
Income before tax
-9,485
-10,516
-9,103
-6,305
-4,225
Income from continuing operations
-9,485
-10,516
-9,103
-6,305
-4,225
Net income
-9,485
-10,516
-9,103
-6,305
-4,225
Net income available to common shareholders
-9,485
-10,516
-9,103
-6,305
-4,225
Basic EPS
-0.77
-0.83
-0.73
-0.58
-0.45
Diluted EPS
-0.77
-0.83
-0.73
-0.58
-0.45
Basic average shares
13,041
12,718
12,471
10,958
9,321
Diluted average shares
13,041
12,718
12,471
10,958
9,321